Sanna, E.; Tanca, L.; Cherchi, C.; Gramignano, G.; Oppi, S.; Chiai, M.G.; Macciò, A.; Madeddu, C.
Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer. Diagnostics 2021, 11, 1298.
https://doi.org/10.3390/diagnostics11071298
AMA Style
Sanna E, Tanca L, Cherchi C, Gramignano G, Oppi S, Chiai MG, Macciò A, Madeddu C.
Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer. Diagnostics. 2021; 11(7):1298.
https://doi.org/10.3390/diagnostics11071298
Chicago/Turabian Style
Sanna, Elisabetta, Luciana Tanca, Cristina Cherchi, Giulia Gramignano, Sara Oppi, Maria Gloria Chiai, Antonio Macciò, and Clelia Madeddu.
2021. "Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer" Diagnostics 11, no. 7: 1298.
https://doi.org/10.3390/diagnostics11071298
APA Style
Sanna, E., Tanca, L., Cherchi, C., Gramignano, G., Oppi, S., Chiai, M. G., Macciò, A., & Madeddu, C.
(2021). Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer. Diagnostics, 11(7), 1298.
https://doi.org/10.3390/diagnostics11071298
